In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

Coinbase Global (COIN) will begin trading on the S&P 500 (^GSPC) effective today, replacing Discover Financial Services (DFS) ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Live Updates Live Coverage Updates appear automatically as they are published. Earnings Season Rolls On 10:04 am by The ...

Live Updates Live Coverage Updates appear automatically as they are published. Retail Earnings on Deck 10:28 am by Gerelyn Terzo With the earnings season still in full swing, corporate America takes ...

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

JP Morgan analyst Puneet Jain upgraded CI&T from Neutral to Overweight and announced a $7 price target. CI&T shares jumped 8.2% to $6.60 on Monday. Markets expect rate cuts — but your earnings don’t ...

Key Takeaways The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine for certain groupsOnly adults 65+ or ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

Nippon Steel plans to invest $14 billion in U.S. Steel's operations including up to $4 billion in a new steel mill if the ...

Novavax finally won approval of a Covid-19 vaccine after facing setback after setback that caused the stock to plunge more ...